Literature DB >> 16021468

Genetic association analyses of PHOX2B and ASCL1 in neuropsychiatric disorders: evidence for association of ASCL1 with Parkinson's disease.

Masayuki Ide1, Kazuo Yamada, Tomoko Toyota, Yoshimi Iwayama, Yuichi Ishitsuka, Yoshio Minabe, Kazuhiko Nakamura, Nobutaka Hattori, Takashi Asada, Yoshikuni Mizuno, Norio Mori, Takeo Yoshikawa.   

Abstract

We previously identified frequent deletion/insertion polymorphisms in the 20-alanine homopolymer stretch of PHOX2B (PMX2B), the gene for a transcription factor that plays important roles in the development of oculomotor nerves and catecholaminergic neurons and regulates the expression of both tyrosine hydroxylase and dopamine beta-hydroxylase genes. An association was detected between gene polymorphisms and overall schizophrenia, and more specifically, schizophrenia with ocular misalignment. These prior results implied the existence of other schizophrenia susceptibility genes that interact with PHOX2B to increase risk of the combined phenotype. ASCL1 was considered as a candidate interacting partner of PHOX2B, as ASCL1 is a transcription factor that co-regulates catecholamine-synthesizing enzymes with PHOX2B. The genetic contributions of PHOX2B and ASCL1 were examined separately, along with epistatic interactions with broader candidate phenotypes. These phenotypes included not only schizophrenia, but also bipolar affective disorder and Parkinson's disease (PD), each of which involve catecholaminergic function. The current case-control analyses detected nominal associations between polyglutamine length variations in ASCL1 and PD (P=0.018), but supported neither the previously observed weak association between PHOX2B and general schizophrenia, nor other gene-disease correlations. Logistic regression analysis revealed the effect of ASCL1 dominant x PHOX2B additive (P=0.008) as an epistatic gene-gene interaction increasing risk of PD. ASCL1 controls development of the locus coeruleus (LC), and accumulating evidence suggests that the LC confers protective effects against the dopaminergic neurodegeneration inherent in PD. The present genetic data may thus suggest that polyglutamine length polymorphisms in ASCL1 could influence predispositions to PD through the fine-tuning of LC integrity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16021468     DOI: 10.1007/s00439-005-1342-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  24 in total

1.  Specification of the central noradrenergic phenotype by the homeobox gene Phox2b.

Authors:  A Pattyn; C Goridis; J F Brunet
Journal:  Mol Cell Neurosci       Date:  2000-03       Impact factor: 4.314

2.  A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes.

Authors:  Heather J Cordell; David G Clayton
Journal:  Am J Hum Genet       Date:  2001-11-21       Impact factor: 11.025

3.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci.

Authors:  P C Sham; D Curtis
Journal:  Ann Hum Genet       Date:  1995-01       Impact factor: 1.670

Review 4.  Genetic and environmental factors in the cause of Parkinson's disease.

Authors:  Thomas T Warner; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

5.  Notch signaling induces rapid degradation of achaete-scute homolog 1.

Authors:  Virote Sriuranpong; Michael W Borges; Christopher L Strock; Eric K Nakakura; D Neil Watkins; Christine M Blaumueller; Barry D Nelkin; Douglas W Ball
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

6.  Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra.

Authors:  G Bing; Y Zhang; Y Watanabe; B S McEwen; E A Stone
Journal:  Brain Res       Date:  1994-12-30       Impact factor: 3.252

Review 7.  Mechanisms of cell death in polyglutamine expansion diseases.

Authors:  Marta M Lipinski; Junying Yuan
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

8.  Localization of the human achaete-scute homolog gene (ASCL1) distal to phenylalanine hydroxylase (PAH) and proximal to tumor rejection antigen (TRA1) on chromosome 12q22-q23.

Authors:  B Renault; J Lieman; D Ward; K Krauter; R Kucherlapati
Journal:  Genomics       Date:  1995-11-01       Impact factor: 5.736

9.  Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases.

Authors:  Chris Zarow; Scott A Lyness; James A Mortimer; Helena C Chui
Journal:  Arch Neurol       Date:  2003-03

Review 10.  Parkinson's disease: piecing together a genetic jigsaw.

Authors:  M C J Dekker; V Bonifati; C M van Duijn
Journal:  Brain       Date:  2003-05-21       Impact factor: 13.501

View more
  9 in total

1.  Efficient discovery of ASCL1 regulatory sequences through transgene pooling.

Authors:  David M McGaughey; Andrew S McCallion
Journal:  Genomics       Date:  2010-03-04       Impact factor: 5.736

Review 2.  Modeling psychiatric disorders at the cellular and network levels.

Authors:  K J Brennand; A Simone; N Tran; F H Gage
Journal:  Mol Psychiatry       Date:  2012-04-03       Impact factor: 15.992

Review 3.  Genetic Regulation of Vertebrate Forebrain Development by Homeobox Genes.

Authors:  Ryan F Leung; Ankita M George; Enola M Roussel; Maree C Faux; Jeffrey T Wigle; David D Eisenstat
Journal:  Front Neurosci       Date:  2022-04-25       Impact factor: 5.152

4.  Neuronal Per Arnt Sim (PAS) domain protein 4 (NPAS4) regulates neurite outgrowth and phosphorylation of synapsin I.

Authors:  Jaesuk Yun; Taku Nagai; Yoko Furukawa-Hibi; Keisuke Kuroda; Kozo Kaibuchi; Michael E Greenberg; Kiyofumi Yamada
Journal:  J Biol Chem       Date:  2012-11-21       Impact factor: 5.157

Review 5.  Modeling psychiatric disorders through reprogramming.

Authors:  Kristen J Brennand; Fred H Gage
Journal:  Dis Model Mech       Date:  2011-10-04       Impact factor: 5.758

6.  Genotype by environment interactions for chronic wasting disease in farmed US white-tailed deer.

Authors:  Christopher M Seabury; Mitchell A Lockwood; Tracy A Nichols
Journal:  G3 (Bethesda)       Date:  2022-07-06       Impact factor: 3.542

7.  Association between AKT1 gene and Parkinson's disease: a protective haplotype.

Authors:  Georgia Xiromerisiou; Georgios M Hadjigeorgiou; Alexandros Papadimitriou; Evaggelos Katsarogiannis; Vasiliki Gourbali; Andrew B Singleton
Journal:  Neurosci Lett       Date:  2008-03-15       Impact factor: 3.046

8.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

9.  Cloning and Functional Analysis of Rat Tweety-Homolog 1 Gene Promoter.

Authors:  Malgorzata Gorniak-Walas; Karolina Nizinska; Katarzyna Lukasiuk
Journal:  Neurochem Res       Date:  2021-06-26       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.